Utilisation of Healthcare and Associated Services in Huntington's disease: a data mining study

Monica Busse, Dr Hasan Al-Madfai, Joyce Kenkre, G Bernhard Landwehrmeyer, Annarita Bentivoglio, Anne Rosser, European Huntington's Disease Network, Monica Busse, Dr Hasan Al-Madfai, Joyce Kenkre, G Bernhard Landwehrmeyer, Annarita Bentivoglio, Anne Rosser, European Huntington's Disease Network

Abstract

Background: People with Huntington's disease (HD) often require tailored healthcare and support packages that develop as the disease progresses. The Client Service Receipt Inventory (CSRI) gathers retrospective information on service utilization. This study investigated the use of formal services and informal care as measured by the CSRI and explored associations between informal care, disease severity and functional ability as measured by the Unified Huntington's Disease Rating Scale Total Motor Score (UHDRS-TMS) and functional scales.

Methods: All monitored longitudinal data from annual clinical assessments of UHDRS-TMS and functional assessments and CSRI collected under the auspices of the European Huntington's Disease Network (EHDN) REGISTRY study between the years 2004 and 2009 were utilised in the analyses. Disease severity was reflected by UHDRS-TMS. Functional ability was measured using the UHDRS functional scales. CSRI data were analysed according to percentage use of individual formal services and total estimated hours per week of informal care. Regression analyses were conducted to identify any associations between disease severity, functional ability and hours of informal care.

Results: 451 HD patients (212 female; 239 male) completed one visit; 105 patients (54 females; 51 males) completed two visits and 47 patients (20 females; 27 males) completed three visits in total over the 5 year period. The mean time between visits was 1.2 years. At visit one, 74% of the participants reported being in receipt of at least one formal hospital-based service in the previous six months, and 89% reported receipt of formal primary and community care services. In contrast, at the third visit, 62% of people had used hospital based services and 94% formal community based services in the previous six months. Fifty % of individuals required some form of informal care in the home at visit 1; this increased to 68% at visits 2 and 3. The mean (SD) estimated weekly total informal care hours at visits 1, 2 and 3 were 32.8 (49.4); 21.6 (53.6) and 21.3 (62.4) respectively. Only the scores on the Functional Assessment Scale (FAS) accounted for the variance in the weekly total informal care hours at each visit.

Conclusions: Although it must be acknowledged that service use is supply driven, most HD patients across Europe surveyed as part of this study were in receipt of formal primary and community care services and to a lesser extent formal hospital based services. There was however a large reliance on informal care in the home. The FAS appear to have predictive value on informal care requirements and may have utility in facilitating pro-active service provision and in particular when managing carer burden in this population.

References

    1. Walker FO. Huntington's disease. Lancet. 2007 Jan 20;369(9557):218-28. Review.
    1. McCabe MP, Roberts C, Firth L. Satisfaction with services among people with progressive neurological illnesses and their carers in Australia. Nurs Health Sci. 2008 Sep;10(3):209-15.
    1. Nance MA. Comprehensive care in Huntington's disease: a physician's perspective. Brain Res Bull. 2007 Apr 30;72(2-3):175-8. Epub 2006 Nov 20. Review.
    1. Dawson S, Kristjanson LJ, Toye CM, Flett P. Living with Huntington's disease: need for supportive care. Nurs Health Sci. 2004 Jun;6(2):123-30.
    1. Wheelock VL, Tempkin T, Marder K, Nance M, Myers RH, Zhao H, Kayson E, Orme C, Shoulson I; Huntington Study Group. Predictors of nursing home placement in Huntington disease. Neurology. 2003 Mar 25;60(6):998-1001.
    1. Aubeeluck A, Wilson E. Huntington's disease. Part 1: essential background and management. Br J Nurs. 2008 Feb 14-27;17(3):146-51. Review.
    1. Moskowitz CB, Marder K. Palliative care for people with late-stage Huntington's disease. Neurol Clin. 2001 Nov;19(4):849-65. Review.
    1. Simpson SA. Late stage care in Huntington's disease. Brain Res Bull. 2007 Apr 30;72(2-3):179-81. Epub 2006 Nov 16. Review.
    1. Skirton H, Glendinning N. Using research to develop care for patients with Huntington's disease. Br J Nurs. 1997 Jan 23-Feb 12;6(2):83-90.
    1. Veenhuizen RB, Tibben A. Coordinated multidisciplinary care for Huntington's disease. An outpatient department. Brain Res Bull. 2009 Oct 28;80(4-5):192-5. Epub 2009 Jul 1.
    1. Aubeeluck A, Moskowitz CB. Huntington's disease. Part 3: family aspects of HD. Br J Nurs. 2008 Mar 13-26;17(5):328-31. Review.
    1. Aubeeluck A. Caring for the carers: quality of life in Huntington's disease. Br J Nurs. 2005 Apr 28-May 11;14(8):452-4. Review.
    1. Williams JK, Skirton H, Paulsen JS, Tripp-Reimer T, Jarmon L, McGonigal Kenney M, Birrer E, Hennig BL, Honeyford J. The emotional experiences of family carers in Huntington disease. J Adv Nurs. 2009 Apr;65(4):789-98. Epub 2009 Feb 9.
    1. Department of Health. The National Service Framework for long term conditions. 2005. London, UK.
    1. Chisholm D, Knapp MR, Knudsen HC, Amaddeo F, Gaite L, van Wijngaarden B. Client Socio-Demographic and Service Receipt Inventory--European Version: development of an instrument for international research. EPSILON Study 5. European Psychiatric Services: Inputs Linked to Outcome Domains and Needs. Br J Psychiatry Suppl. 2000;(39):s28-33.
    1. Beecham, J and Knapp, M. Costing Psychiatric Interventions, in Measuring Mental Health Needs, Eds.Thornicroft G, Brewin C & Wing JK. 1992. Gaskell: London.
    1. Schneider J, Hallam A, Murray J, Foley B, Atkin L, Banerjee S, Islam MK, Mann A. Formal and informal care for people with dementia: factors associated with service receipt. Aging Ment Health. 2002 Aug;6(3):255-65.
    1. Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group. Mov Disord. 1996 Mar;11(2):136-42.
    1. Shoulson I, Fahn S. Huntington disease: clinical care and evaluation. Neurology. 1979 Jan;29(1):1-3.
    1. Orth M; European Huntington's Disease Network, Handley OJ, Schwenke C, Dunnett SB, Craufurd D, Ho A, Wild EJ, Tabrizi SJ. Observing Huntington's Disease: the European Huntington's Disease Network's REGISTRY. PLoS Curr. 2010 Sep 28;2. pii: RRN1184.
    1. Currie G, Kerfoot KD, Donaldson C, Macarthur C. Are cost of injury studies useful? Inj Prev. 2000 Sep;6(3):175-6.
    1. Busse ME, Khalil H, Quinn L, Rosser AE. Physical therapy intervention for people with Huntington disease. Phys Ther. 2008 Jul;88(7):820-31. Epub 2008 May 8.
    1. Freeman JA, Thompson AJ. Community services in multiple sclerosis: still a matter of chance. J Neurol Neurosurg Psychiatry. 2000 Dec;69(6):728-32.
    1. Phillips VL. Community care for severely disabled people on low incomes. BMJ. 1995 Oct 28;311(7013):1121-3.
    1. Williams MH, Bowie C. Evidence of unmet need in the care of severely physically disabled adults. BMJ. 1993 Jan 9;306(6870):95-8. Retraction in: BMJ. 1998 Jun 6;316(7146):1700.
    1. Bernard S, Aspinal F, Gridley K, Parker G. Integrated policy making in England for adults with long-term neurological conditions (LTNCs): some preliminary findings from a scoping study. Int J Integr Care. 2008 Jul 14;8:e60.

Source: PubMed

3
購読する